The pharmaceutical industry is continually seeking novel approaches to create and identify effective treatments that cater to medical requirements. The procedure of discovering drugs is a daunting process that demands

Artificial intelligence is revolutionising the pharmaceutical and biotechnology industries. Its unparalleled power to make predictions based on large data sets is advancing understanding of diseases, improving diagnostic speed and accuracy,

Poolbeg Pharma plc has been granted a patent by the US Patent and Trademark Office (USPTO) for ways of treating hypercytokinaemia using a small molecule immunomodulator. The US patent covers

The use of artificial intelligence (AI) in drug discovery is revolutionizing the pharmaceutical industry. AI-driven drug discovery has the potential to reduce the time and cost of drug development, while also improving

Poolbeg Pharma plc (LON:POLB) is a clinical stage infectious disease pharmaceutical company, with a novel capital light clinical model which enables us to develop multiple products faster and more cost

Renowned futurist Ray Kurzweil has predicted a seismic shift in the balance of power between man and machine: a momentous occasion he calls “the singularity”. This prophecy foresees a time,

Health I see several ways in which AIs will improve health care and the medical field. For one thing, they’ll help health-care workers make the most of their time by

Poolbeg Pharma, an infectious disease-focused biopharmaceutical company, has announced data from the bacterial lipopolysaccharide (‘LPS’) human challenge trial for POLB 001, a viral strain agnostic, small molecule immunomodulator being developed